Value in Health, the official journal of ISPOR, the international pharmacoeconomics/HEOR organization, focuses on AI in HEOR for November 2025.
I clip the article list below; many are open access.
I also clip an AI summary of the TOC below.
###
AI Corner
###
The November AI HEOR Special Issue
This special issue of Value in Health is devoted to the accelerating role of generative and analytical artificial intelligence in health economics and outcomes research (HEOR). Two ISPOR Working Group Reports anchor the issue. The first proposes a taxonomy of generative AI and large language models (LLMs) for HEOR, aiming to standardize terminology and clarify use cases across evidence synthesis, modeling, and decision frameworks. The companion report introduces ELEVATE-GenAI, a structured reporting guideline and checklist to improve transparency, reproducibility, and methodological rigor when LLMs are used in HEOR studies.
A themed section of research articles and editorials then explores how AI is reshaping HEOR practice. An introductory editorial highlights the rapid evolution of AI methods and the corresponding need for standards, validation, and governance. Another article recognizes early-career researchers whose work advances AI-enabled HEOR.
Several empirical studies examine AI’s performance in systematic reviews, traditionally one of the most labor-intensive components of HEOR. Validating “Loon Lens 1.0,” investigators demonstrate 99% recall with confidence-guided human-in-the-loop checks, reducing manual review requirements to <6%. Other teams show that LLMs can accurately extract CEA data, select statistical models, and even execute components of network meta-analyses. The A4SLR framework offers a formalized, agentic AI-supported workflow for systematic literature reviews and HTA evidence synthesis, while a large systematic review finds that generative AI is useful for question formulation and data extraction but still unreliable for literature search, study selection, and bias assessment.
Beyond evidence synthesis, additional studies explore how AI may adapt Excel-based health economic models, generate technical reports, and create synthetic datasets to expand research accessibility and privacy protection. A final survey of public preferences in Australia finds that for AI-driven mobile health apps, accuracy remains the dominant factor, followed by how well clinicians and AI systems collaborate.
###
###
|
|
|